ETF Holdings Breakdown of SNY

Stock Name	Sanofi ADR
Ticker	SNY(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US80105N1054
LEI	549300E9PC51EN656011

News associated with SNY

Sanofi Q1 Results Climb; Confirms FY25 Outlook: (RTTNews) - French drug major Sanofi (SNY)' reported Thursday higher profit in its first quarter, with growth in net sales. Further, the company confirmed its fiscal 2025 outlook. - 2025-04-24 05:50:11
Mariner LLC Raises Stock Holdings in Sanofi (NASDAQ:SNY): Mariner LLC lifted its holdings in Sanofi (NASDAQ:SNY – Free Report) by 8.0% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 108,997 shares of the company’s stock after purchasing an additional 8,107 shares during the quarter. Mariner LLC’s holdings in Sanofi were worth […] - 2025-04-21 08:08:56
Sanofi Reveals Progress In Mid To Late Stage Respiratory Pipeline; Plans New COPD Clinical Studies: (RTTNews) - French drugmajor Sanofi (SNY) announced Tuesday new progress from its mid- to late-stage respiratory pipeline, including preliminary phase 2 results for amlitelimab in adults with moderate-to-severe asthma. - 2025-04-15 06:08:26
Analysts Set Sanofi (NASDAQ:SNY) PT at $60.00: Sanofi (NASDAQ:SNY – Get Free Report) has been assigned an average recommendation of “Buy” from the five analysts that are currently covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold rating, one has assigned a buy rating and two have given a strong buy rating to the company. […] - 2025-03-26 06:42:46
Sanofi (NASDAQ:SNY) Coverage Initiated at The Goldman Sachs Group: The Goldman Sachs Group started coverage on shares of Sanofi (NASDAQ:SNY – Free Report) in a research report sent to investors on Friday morning, Marketbeat Ratings reports. The firm issued a neutral rating and a $65.00 target price on the stock. Other research analysts also recently issued research reports about the stock. StockNews.com downgraded shares […] - 2025-03-24 06:34:45
HighTower Advisors LLC Boosts Holdings in Sanofi (NASDAQ:SNY): HighTower Advisors LLC increased its position in shares of Sanofi (NASDAQ:SNY – Free Report) by 3.4% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 91,071 shares of the company’s stock after buying an additional 2,971 shares during the quarter. HighTower Advisors LLC’s holdings […] - 2025-03-20 08:42:49
SNY Quantitative Stock Analysis: Below is Validea's guru fundamental report for SANOFI SA (ADR) (SNY). Of the 22 guru strategies we follow, SNY rates highest using our Acquirer's Multiple Investor model based on the published strategy of Tobias Carlisle. This deep value model looks for inexpensive stocks that c - 2025-03-18 18:57:59
Daiwa Securities Group Inc. Reduces Stock Holdings in Sanofi (NASDAQ:SNY): Daiwa Securities Group Inc. lowered its position in Sanofi (NASDAQ:SNY – Free Report) by 81.6% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 994 shares of the company’s stock after selling 4,398 shares during the period. Daiwa Securities Group Inc.’s holdings in Sanofi were worth $48,000 at the end of the most recent […] - 2025-03-18 07:42:49
Sanofi (NASDAQ:SNY) Shares Purchased by Jones Financial Companies Lllp: Jones Financial Companies Lllp raised its stake in Sanofi (NASDAQ:SNY – Free Report) by 55.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 15,122 shares of the company’s stock after purchasing an additional 5,366 shares during the period. Jones Financial Companies Lllp’s […] - 2025-03-10 08:37:07
Keybank National Association OH Raises Stock Holdings in Sanofi (NASDAQ:SNY): Keybank National Association OH grew its stake in Sanofi (NASDAQ:SNY – Free Report) by 9.9% during the 4th quarter, Holdings Channel reports. The fund owned 10,105 shares of the company’s stock after acquiring an additional 913 shares during the period. Keybank National Association OH’s holdings in Sanofi were worth $487,000 at the end of the […] - 2025-03-10 07:54:51
Sanofi Signs Share Purchase Deal To Sell 50% Controlling Stake In Opella To CD&R: (RTTNews) - French drug major Sanofi (SNYNF, SNY) announced Wednesday that it has signed the share purchase agreement for the sale of a 50% controlling stake in its consumer healthcare business, Opella, to private equity firm CD&R. - 2025-02-19 06:55:30
Valeo Financial Advisors LLC Sells 8,976 Shares of Sanofi (NASDAQ:SNY): Valeo Financial Advisors LLC decreased its holdings in Sanofi (NASDAQ:SNY – Free Report) by 62.0% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 5,496 shares of the company’s stock after selling 8,976 shares during the quarter. Valeo Financial Advisors LLC’s holdings in Sanofi […] - 2025-02-18 09:14:52
Savant Capital LLC Boosts Position in Sanofi (NASDAQ:SNY): Savant Capital LLC raised its stake in Sanofi (NASDAQ:SNY – Free Report) by 24.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 6,361 shares of the company’s stock after acquiring an additional 1,264 shares during the quarter. Savant Capital LLC’s holdings […] - 2025-02-18 08:22:55
Regeneron & Sanofi : FDA Accepts Dupixent SBLA For Priority Review In Bullous Pemphigoid Treatment: (RTTNews) - The U.S. Food and Drug Administration has accepted for Priority Review the supplemental Biologics License Application or sBLA for Dupixent (dupilumab) to treat adults with bullous pemphigoid, Regeneron Pharmaceuticals Inc. (REGN) and Sanofi (SNYNF, SNY) said in a stat - 2025-02-18 06:25:28
Stratos Wealth Partners LTD. Sells 613 Shares of Sanofi (NASDAQ:SNY): Stratos Wealth Partners LTD. lessened its holdings in Sanofi (NASDAQ:SNY – Free Report) by 10.8% during the 4th quarter, HoldingsChannel reports. The firm owned 5,057 shares of the company’s stock after selling 613 shares during the period. Stratos Wealth Partners LTD.’s holdings in Sanofi were worth $244,000 at the end of the most recent reporting […] - 2025-02-14 08:29:01
Yousif Capital Management LLC Purchases 20,690 Shares of Sanofi (NASDAQ:SNY): Yousif Capital Management LLC lifted its holdings in shares of Sanofi (NASDAQ:SNY – Free Report) by 53.2% in the fourth quarter, Holdings Channel.com reports. The fund owned 59,611 shares of the company’s stock after purchasing an additional 20,690 shares during the period. Yousif Capital Management LLC’s holdings in Sanofi were worth $2,875,000 at the end […] - 2025-02-10 18:52:59
abrdn plc Raises Stock Holdings in Sanofi (NASDAQ:SNY): abrdn plc raised its position in shares of Sanofi (NASDAQ:SNY – Free Report) by 25.6% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 314,180 shares of the company’s stock after buying an additional 64,095 shares during the period. abrdn plc’s holdings in Sanofi […] - 2025-02-08 08:54:51
Sanofi To Repurchase EUR 2 Bln Worth Of Shares: (RTTNews) - Sanofi (SNY), a French pharmaceutical and healthcare company, Friday announced that it is executing the second tranche of its share buyback program, to repurchase up to 2 billion euros worth shares. Sanofi has signed a mandate with an investment service provider fo - 2025-02-07 07:18:38
Brokerages Set Sanofi (NASDAQ:SNY) Price Target at $60.00: Shares of Sanofi (NASDAQ:SNY – Get Free Report) have earned a consensus recommendation of “Buy” from the four brokerages that are currently covering the firm, Marketbeat reports. One analyst has rated the stock with a hold rating, one has given a buy rating and two have assigned a strong buy rating to the company. The […] - 2025-02-04 06:56:52
Perigon Wealth Management LLC Lowers Stake in Sanofi (NASDAQ:SNY): Perigon Wealth Management LLC cut its position in Sanofi (NASDAQ:SNY – Free Report) by 25.6% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 6,417 shares of the company’s stock after selling 2,207 shares during the period. Perigon Wealth Management LLC’s holdings in Sanofi were worth $326,000 as […] - 2025-02-03 08:51:13

SNY institutional holdings

The following institutional investment holdings of SNY have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-08 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 136,780 USD 7,130,341

2025-05-08 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 136,780 USD 7,130,341 -0.3%

Total = 273,560 USD 14,260,682
Book value of shares is calculated on the adjusted close price of each day (row).

Date	ETF ISIN/Name	Num Shares	Book value
2025-05-08	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	136,780	USD 7,130,341
2025-05-08	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	136,780	USD 7,130,341 -0.3%
Total =	273,560	USD 14,260,682

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.